文献

J-GLOBAL ID：202102226750721623   整理番号：21A0157597

二次的大動脈腸瘻患者の類似生存におけるin situバイパスおよび解剖学的バイパス手術の結果【JST・京大機械翻訳】

In situ bypass and extra-anatomic bypass procedures result in similar survival in patients with secondary aortoenteric fistulas

著者 (77件)： Janko Matthew R. (Division of Vascular Surgery and Endovascular Therapy, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio) ,  Woo Karen (Ronald Reagan UCLA Medical Center, University of California Los Angeles, Los Angeles, Calif) ,  Hacker Robert I. (Division of Vascular Surgery, Mercy Hospital, Toledo, Ohio) ,  Baril Donald (Ronald Reagan UCLA Medical Center, University of California Los Angeles, Los Angeles, Calif) ,  Bath Jonathan (Division of Vascular Surgery, University Hospital, University of Missouri, Columbia, Mo) ,  Smeds Matthew R. (Division of Vascular Surgery, SSM Health St. Louis University, St. Louis, Mo) ,  Kashyap Vikram S. (Division of Vascular Surgery and Endovascular Therapy, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio) ,  Szeberin Zoltan (Department of Vascular Surgery, Semmelweis University, Budapest, Hungary) ,  Magee Gregory A. (Division of Vascular Surgery and Endovascular Therapy, Keck School of Medicine, University of Southern California, Los Angeles, Calif) ,  Elsayed Ramsey (Division of Vascular Surgery and Endovascular Therapy, Keck School of Medicine, University of Southern California, Los Angeles, Calif) ,  Wishy Andrew (Division of Vascular Surgery, University of California Davis, Davis, Calif) ,  St. John Rebecca (Division of Vascular Surgery and Endovascular Therapy, University of Alabama, Birmingham, Ala) ,  Beck Adam (Division of Vascular Surgery and Endovascular Therapy, University of Alabama, Birmingham, Ala) ,  Farber Mark (Division of Vascular Surgery, University of North Carolina School of Medicine, Chapel Hill, NC) ,  Motta Fernando (Division of Vascular Surgery, University of North Carolina School of Medicine, Chapel Hill, NC) ,  Zhou Wei (Division of Vascular and Endovascular Surgery, University of Arizona, Tucson, Ariz) ,  Lemmon Gary (Indiana University Health Physicians Vascular Surgery, Indianapolis, Ind) ,  Coleman Dawn (Division of Vascular Surgery, Michigan Medicine, University of Michigan, Ann Arbor, Mich) ,  Behrendt Christian-Alexander (Department of Vascular Medicine, University Heart Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany) ,  Aziz Faisal (Penn State Heart and Vascular Institute, Milton S. Hershey Medical Center, Hershey, Pa) ,  Black James (Division of Vascular Surgery and Endovascular Therapy, Johns Hopkins Hospital, Baltimore, Md) ,  Shutze William (Division of Vascular Surgery, The Heart Hospital Baylor Plano, Plano, Tex) ,  Garrett H. Edward (Cardiovascular Surgery Clinic, Memphis, Tenn) ,  De Caridi Giovanni (Division of Vascular Surgery, University of Messina, Messina, Italy) ,  Liapis Christos D. (Department of Vascular Surgery, National & Kapodistrian University of Athens, Athens, Greece) ,  Geroulakos George (Department of Vascular Surgery, National & Kapodistrian University of Athens, Athens, Greece) ,  Kakisis John (Department of Vascular Surgery, National & Kapodistrian University of Athens, Athens, Greece) ,  Moulakakis Konstantinos (Department of Vascular Surgery, National & Kapodistrian University of Athens, Athens, Greece) ,  Kakkos Stavros K. (Division of Vascular Surgery, University of Patras, Patras, Greece) ,  Obara Hideaki (Division of Vascular Surgery, Keio University, Tokyo, Japan) ,  Wang Grace (Division of Vascular Surgery and Endovascular Therapy, University of Pennsylvania, Philadelphia, Pa) ,  Rheaume Pascal (Division of Vascular Surgery, Vancouver General Hospital & University of British Columbia, Vancouver, British Columbia, Canada) ,  Davila Victor (Division of Vascular Surgery, Mayo Clinic, Phoenix, Ariz) ,  Ravin Reid (Division of Vascular and Endovascular Surgery, Mount Sinai - New York, New York, NY) ,  DeMartino Randall (Division of Vascular Surgery and Endovascular Therapy, Mayo Clinic, Rochester, Minn) ,  Milner Ross (Division of Vascular Surgery, University of Chicago, Chicago, Ill) ,  Shalhub Sherene (Division of Vascular Surgery, Harborview Medical Center, University of Washington, Seattle, Wash) ,  Jim Jeffrey (Section of Vascular Surgery, Washington University, St. Louis, Mo) ,  Lee Jason (Division of Vascular and Endovascular Surgery, Stanford University, Stanford, Calif) ,  Dubuis Celine (Division of Vascular and Endovascular Surgery, Stanford University, Stanford, Calif) ,  Ricco Jean-Baptiste (Vascular Surgery, Hopital Jean Bernard, CHU de Poitiers, Poitiers, France) ,  Coselli Joseph (Department of Cardiothoracic Surgery, Baylor College of Medicine, Houston, Tex) ,  Lemaire Scott (Department of Cardiothoracic Surgery, Baylor College of Medicine, Houston, Tex) ,  Fatima Javairiah (Division of Vascular Surgery, MedStar Georgetown University Hospital, Washington, D.C.) ,  Sanford Jennifer (Division of Vascular Surgery, SSM Health St. Louis University, St. Louis, Mo) ,  Yoshida Winston (Department of Vascular Surgery, Faculdade de Botucatu, Botucatu, Brazil) ,  Schermerhorn Marc L. (Division of Vascular and Endovascular Surgery, Beth Israel Deaconness Medical Center, Boston, Mass) ,  Menard Matthew (Division of Vascular and Endovascular Surgery, Brigham and Women’s Hospital, Boston, Mass) ,  Belkin Michael (Division of Vascular and Endovascular Surgery, Brigham and Women’s Hospital, Boston, Mass) ,  Blackwood Stuart (Division of Vascular and Endovascular Surgery, Brigham and Women’s Hospital, Boston, Mass) ,  Conrad Mark (Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, Mass) ,  Wang Linda (Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, Mass) ,  Crofts Sara (Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, Mass) ,  Nixon Thomas (Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, Mass) ,  Wu Timothy (Division of Vascular Surgery and Endovascular Therapy, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ) ,  Chiesa Roberto (Department of Vascular Surgery, Vita-Salute University School of Medicine, San Raffaele Scientific Institute, Milan, Italy) ,  Bose Saideep (Division of Vascular Surgery and Endovascular Therapy, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio) ,  Turner Jason (Division of Vascular Surgery and Endovascular Therapy, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio) ,  Moore Ryan (Division of Vascular Surgery and Endovascular Therapy, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio) ,  Smith Justin (Division of Vascular Surgery and Endovascular Therapy, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio) ,  Ciocca Rocco (Division of Vascular Surgery and Endovascular Therapy, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio) ,  Hsu Jeffrey (Division of Vascular Surgery, Kaiser Permanente, Fontana, Calif) ,  Czerny Martin (Department of Cardiovascular Surgery, University Heart Center Freiburg-Bad Krozingen Freiburg, Germany) ,  Cullen Jonathan (Division of Vascular and Endovascular Surgery, University of Virginia Medical Center, Charlottesville, Va) ,  Kahlberg Andrea (Department of Vascular Surgery, Vita-Salute University School of Medicine, San Raffaele Scientific Institute, Milan, Italy) ,  Setacci Carlo (Division of Vascular and Endovascular Surgery, University of Siena, Siena, Italy) ,  Joh Jin Hyun (Division of Vascular Surgery, Kyung Hee University, Seoul, South Korea) ,  Senneville Eric (Division of Vascular Surgery, Gustave Dron Hospital, Tourcoing, France) ,  Garrido Pedro (Division of Vascular Surgery, Centro Hospitalar de Lisboa Norte, Lisbon, Portugal) ,  Sarac Timur P. (Division of Vascular Surgery, Wexner Medical Center, Ohio State University, Columbus, Ohio) ,  Rizzo Anthony (Division of Vascular Surgery, Wexner Medical Center, Ohio State University, Columbus, Ohio) ,  Go Michael R. (Division of Vascular Surgery, Wexner Medical Center, Ohio State University, Columbus, Ohio) ,  Bjorck Martin (Department of Surgical Sciences Vascular Surgery, Uppsala University, Uppsala, Sweden) ,  Gavali Hamid (Department of Surgical Sciences Vascular Surgery, Uppsala University, Uppsala, Sweden) ,  Wanhainen Anders (Department of Surgical Sciences Vascular Surgery, Uppsala University, Uppsala, Sweden) ,  Lawrence Peter F. (Ronald Reagan UCLA Medical Center, University of California Los Angeles, Los Angeles, Calif) ,  Chung Jayer (Division of Vascular Surgery and Endovascular Therapy, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Tex)
資料名： Journal of Vascular Surgery  (Journal of Vascular Surgery)
巻： 73  号： 1  ページ： 210-221.e1  発行年： 2021年 
JST資料番号： W3194A  ISSN： 0741-5214  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： オランダ (NLD)  言語： 英語 (EN)

抄録/ポイント： 二次大動脈腸瘻(SAEF)における最適な血管再生様式は,文献において不明のままである。本研究の目的は,SAEF患者における実世界データを用いて,最も低い罹患率と死亡率に関連する血行再建アプローチを決定することであった。2002年から2014年までのSAEFの遡及的,多施設研究を標準化データベースを用いて行った。ベースライン人口統計学,共存症および手術および術後変数を記録した。一次転帰は長期死亡率であった。記述統計学,Kaplan-Meier生存解析,単変量および多変量解析を実施した。研究期間中に,11か国からの34施設での182人の患者は,SAEF(年齢中央値,72歳;79%男性)を示した。SAEFをもたらす初期大動脈処置は,138の外科的移植片(76%)と42の内移植片(23%)で,2つの未知であった。SAEFsの102(56%)は,感染大動脈移植片材料の完全な切除を受け,続いて,抗生物質浸漬人工移植片(53),自己大腿静脈(neoaortoiliac手術;17),凍結保存同種移植片(28),および未治療人工移植片(4)を含むin situ(インライン)バイパス(ISB)を行った。感染移植片切除を伴う外解剖学的バイパス(EAB)を受けた80人の患者(44%)があった。Kaplan-Meier推定生存率の中央値は319日(四分位範囲,20~2410日)であった。EAB対ISBにより層別化して,Kaplan-Meier推定生存率に有意差はみられなかった(P=0.82)。EAB対ISBの比較において,EAB患者はより高齢(74対70歳;P=0.01)で,術後30日(15%対5%;P=0.02)以内に透析を開始し,術後30日以内に大動脈関連出血(15%対5%;P=0.02)を発症し,術後30日以内に大動脈関連出血を経験しなかった(3%大動脈断端離開対11%吻合破裂;P=0.03)。そうでなければ,提示,共存症,および術中または術後変数に有意差は認められなかった。多変量Cox回帰は,抗生物質使用期間(ハザード比,0.92;95%信頼区間,0.86~0.98;P=0.01)と退院時のリファンピン使用(ハザード比,0.20;95%信頼区間,0.05~0.86;P=0.03)が死亡率を独立して減少させたことを示した。これらのデータは,ISBがEABと比較して生存利点を提供しず,術後大動脈関連出血のリスクを低下させないことを示唆する。修復後,SAEF患者の<50%は10か月生存した。抗生物質使用の各週は死亡率を8%減少させた。リスクモデリングによる更なる研究は,この集団にとって不可欠である。Copyright 2021 Elsevier B.V., Amsterdam. All rights reserved. Translated from English into Japanese by JST.【JST・京大機械翻訳】

シソーラス用語： 多変量解析 ,  データベース ,  標準化 ,  抗生物質 ,  死亡率 ,  出血 ,  *大動脈 ,  層別 ,  生存率 ,  *解剖学 ,  吻合術 ,  大腿静脈 ,  *腸瘻 ,  外科的血行再建術 ,  改変 ,  抗細菌薬 ,  抗微生物薬 ,  薬物
準シソーラス用語： *バイパス術 , 【Automatic Indexing@JST】

著者キーワード (2件)： 大動脈腸管瘻 ,  大動脈

分類 (1件)： 循環系疾患の外科療法  (GJ05030X)

タイトルに関連する用語 (8件)： 大動脈 ,  腸瘻 ,  患者 ,  類似 ,  生存 ,  バイパス ,  解剖学 ,  バイパス手術